IMAC Holdings, Inc. Financial Summary

Complete Filing Data

IMAC Holdings, Inc. reported Net Income Loss of -$9.05 million for FY2024.

All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean IMAC Holdings, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.

Income Statement

Annual (10-K / 20-F)

Metric \ Fiscal YearFY2024FY2023FY2022FY2021FY2020FY2019FY2018
Net Income *-$9.0M-$9.4M-$18.3M-$10.5M-$5.0M-$6.5M-$3.1M
Revenue *$72.1K$16.2M$14.4M$12.8M$15.1M$6.7M
Operating Income Loss-$5.6M-$6.4M-$11.8M-$10.1M-$6.5M-$6.2M-$3.6M
Operating Expenses$5.4M$6.4M$11.8M$24.5M$19.4M$21.3M$10.3M
Nonoperating Income Expense-$674.5K-$99.9K$6.1K-$443.9K$993.9K-$766.0K-$127.9K
General And Administrative Expense$5.4M$2.9M$2.5M$6.4M$4.6M$5.1M$3.1M
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest-$6.3M-$6.5M-$11.8M-$10.5M-$5.5M-$7.0M-$3.8M
Interest Expense$125.0K$3.2K$504.1K$563.1K$258.5K$153.8K
Net Income Loss Attributable To Noncontrolling Interest-$538.7K-$454.4K$731.1K
Other Nonoperating Income Expense-$2.0K-$574.00$57.3K$6.00-$16.1K$18.4K
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments-$7.0M-$3.7M
Net Income Loss Available To Common Stockholders Basic-$10.3M-$9.5M
Cost Of Revenue$305.2K
Income Loss From Continuing Operations Per Diluted Share-$4.01-$5.82-$12.55
Income Loss From Continuing Operations Per Basic Share-$4.01-$5.82-$12.55

Quarterly (10-Q, single quarters)

Metric \ QuarterQ3 2025Q2 2025Q1 2025Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021Q3 2020Q2 2020Q1 2020Q3 2019Q2 2019Q1 2019Q3 2018Q2 2018Q1 2018
Net Income *-$3.1M-$2.1M-$2.2M-$2.2M-$1.4M-$407.2K-$2.9M-$1.4M-$3.7M-$6.3M-$1.8M-$3.2M-$2.9M-$2.5M-$2.2M-$1.4M-$2.0M-$1.7M-$1.5M-$1.9M-$1.6M-$979.7K-$732.0K-$404.7K
Revenue *$21.2K$1.5K$56.3K$15.8K$1.6M$1.3M$2.1M$3.8M$5.0M$3.9M$3.5M$3.5M$3.1M$3.5M$2.6M$3.3M$4.4M$3.8M$2.8M$2.5M$634.7K$267.9K
Operating Income Loss-$2.6M-$2.0M-$2.2M-$2.0M-$1.4M-$408.6K-$3.3M-$1.1M-$1.3M-$6.3M-$1.8M-$3.1M-$2.8M-$2.4M-$2.1M-$1.3M-$1.7M-$2.0M-$1.6M-$2.1M-$1.3M-$1.2M-$917.8K-$584.0K
Operating Expenses$2.5M$1.9M$2.1M$1.9M$1.3M$408.6K$3.3M$1.1M$1.3M$10.1M$6.8M$7.0M$6.3M$5.9M$5.1M$4.8M$4.3M$5.3M$6.0M$5.9M$4.1M$3.7M$1.6M$851.8K
Nonoperating Income Expense-$466.6K-$148.2K-$11.3K-$105.2K-$11.2K-$40.3K-$44.0K-$21.2K-$844.00$12.5K-$42.9K-$17.3K-$105.7K-$126.0K-$176.3K-$164.6K-$265.7K-$76.2K-$74.4K-$84.5K-$685.8K-$43.7K-$12.3K-$20.2K
General And Administrative Expense$1.8M$1.9M$2.1M$1.9M$1.3M$408.6K$996.6K$835.8K$603.4K$1.9M$1.9M$1.8M$1.6M$1.7M$1.2M$961.5K$1.2M$1.2M$1.3M$1.4M$977.4K$1.0M$737.1K$239.7K
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest-$3.1M-$2.1M-$2.2M-$2.1M-$1.4M-$448.9K-$3.3M-$1.2M-$1.3M-$6.3M-$1.8M-$3.2M-$2.9M-$2.5M-$2.2M-$1.5M-$2.0M-$2.1M-$1.7M-$2.2M-$2.0M-$1.3M-$950.0K-$689.9K
Interest Expense$40.5K$71.8K$22.4K$846.00$3.0K$4.7K$4.1K$108.3K$126.2K$176.3K$141.4K$134.9K$76.2K$74.5K$85.2K$30.7K$45.8K$32.7K$23.6K
Net Income Loss Attributable To Noncontrolling Interest-$1.2M-$542.7K-$239.4K-$42.7K$55.6K-$336.6K-$163.0K-$295.7K$431.2K-$276.3K-$218.0K-$285.2K
Other Nonoperating Income Expense$84.7K$12.7K-$39.5K-$13.2K$816.00$243.00$6.00-$94.00$665.00-$16.0K$18.4K
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments-$1.7M-$2.2M-$2.0M-$1.3M-$930.1K-$604.2K
Net Income Loss Available To Common Stockholders Basic-$4.4M-$3.4M-$3.4M-$3.4M-$2.0M-$616.6K-$2.9M-$1.4M-$6.3M
Cost Of Revenue$123.9K$102.3K$103.2K$122.1K$72.0K
Income Loss From Continuing Operations Per Diluted Share-$1.15-$0.89-$1.08-$1.71-$1.74-$0.39-$3.04-$1.05-$1.18
Income Loss From Continuing Operations Per Basic Share-$1.15-$0.89-$1.08-$1.71-$1.74-$0.39-$3.04-$1.05-$1.18

Balance Sheet

Annual (10-K / 20-F)

Metric \ Fiscal YearFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Stockholders Equity *$4.7M$18.0M$7.8M$7.9M-$3.9M$173.5K
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations$763.2K$7.1M$2.6M$373.7K$194.3K$127.8K
Retained Earnings Accumulated Deficit-$55.9M-$46.5M-$28.2M-$17.7M-$12.1M-$3.5M
Liabilities Current$1.9M$6.4M$4.9M$6.0M$6.1M$13.8M
Liabilities And Stockholders Equity$1.1M$11.1M$27.2M$19.7M$20.4M$11.1M
Common Stock Value$1.1K$1.1K$26.2K$12.7K$8.9K$4.5K
Assets Current$1.1M$10.8M$9.1M$4.8M$2.6M$668.1K
Assets$1.1M$11.1M$27.2M$19.7M$20.4M$11.1M
Accounts Payable And Accrued Liabilities Current$454.1K$568.6K$2.5M$1.7M$2.9M$1.3M
Cash And Cash Equivalents At Carrying Value$763.2K$7.1M$2.6M$373.7K$194.3K
Repayments Of Notes Payable$10.4K$254.5K$4.4M$1.5M$123.3K$193.6K
Liabilities$8.0M$1.9M$6.4M$9.3M$11.9M$12.5M$15.0M
Other Assets Current$191.1K$547.5K$310.4K$633.3K$170.2K
Property Plant And Equipment Net$5.4K$2.3M$1.8M$3.7M$3.3M
Long Term Notes Payable$104.7K$2.1M$317.3K
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect$282.7K-$541.7K-$6.4M$4.5M$2.3M$179.4K$66.5K
Notes Payable Current$254.5K$1.4M$4.5M
Accounts Receivable Net Current$1.2M$1.5M$1.3M$303.6K
Repayments Of Debt And Capital Lease Obligations$1.7K$27.5K$19.1K$25.5K$17.5K$16.7K$25.6K
Deposit Liability Current$320.9K$295.1K$189.7K$454.4K
Gain Loss On Disposition Of Assets1-$1.5M-$98.1K-$149.5K-$63.8K$140.1K
Gain Loss On Disposition Of Assets-$3.4M-$4.5M-$149.5K-$63.8K
Intangible Assets Net Excluding Goodwill$243.8K$5.8M$6.6M$7.2M$4.3M
Other Assets$15.8M$13.2M$14.1M$7.1M
Liability To Issue Common Stock Current$329.9K$337.9K$339.4K$421.0K
Operating Lease Right Of Use Asset$4.9M$3.8M$3.7M
Operating Lease Liability Noncurrent$4.0M$3.5M$3.7M
Operating Lease Liability Current$1.5M$1.1M$1.0M
Minority Interest-$2.1M-$1.6M
Finance Lease Liability Current$19.1K$18.2K$17.5K$16.7K
Finance Lease Liability Noncurrent$29.3K$48.3K$66.6K$84.0K

Quarterly (10-Q, single quarters)

Metric \ QuarterQ3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020Q2 2020Q1 2020Q3 2019Q2 2019Q1 2019Q3 2018Q2 2018Q1 2018Q4 2017
Stockholders Equity *-$13.0M-$9.8M-$7.6M-$5.6M-$4.0M-$1.8M-$1.2M-$752.6K$1.0M-$359.0K$997.0K$11.6M$14.1M$15.0M$18.0M$19.5M$22.4M$22.8M$7.8M$6.5M$7.9M$7.3M$7.8M$9.3M$7.1M-$3.0M-$1.8M-$518.4K
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations$45.1K$42.7K$30.9K$504.2K$195.5K$890.6K$17.5K$221.5K$224.6K$247.0K$390.1K$2.8M$1.6M$4.3M$11.2M$13.6M$15.6M$1.7M$2.8M$1.3M$740.9K$2.2M$3.1M$241.9K$212.6K
Retained Earnings Accumulated Deficit-$72.4M-$69.3M-$67.2M-$65.0M-$59.9M-$57.7M-$56.3M-$54.5M-$51.6M-$50.2M-$39.5M-$33.2M-$31.4M-$8.6M-$7.0M-$5.1M
Liabilities Current$13.3M$10.9M$8.8M$7.2M$6.3M$4.5M$2.2M$2.5M$3.9M$3.5M$3.9M$4.6M$5.2M$5.4M$5.4M$6.6M$6.0M$8.8M$9.3M$5.9M$6.2M$6.5M
Liabilities And Stockholders Equity$310.1K$1.1M$1.1M$1.6M$1.5M$2.2M$910.8K$4.3M$4.6M$5.8M$18.5M$22.1M$24.2M$29.2M$32.5M$33.6M$19.4M$21.9M$21.1M$21.0M$22.4M$18.0M
Common Stock Value$1.3K$1.3K$1.3K$1.2K$1.2K$1.2K$1.1K$1.1K$33.3K$33.0K$32.5K$27.3K$26.4K$25.3K$25.3K$24.0K$11.8K$11.8K$10.0K$8.5K$8.3K$7.3K
Assets Current$310.1K$277.1K$287.6K$684.3K$510.7K$1.2M$910.8K$2.1M$1.3M$1.8M$6.5M$5.4M$6.7M$13.5M$16.3M$18.3M$3.8M$4.9M$3.5M$2.2M$4.0M$4.1M
Assets$310.1K$1.1M$1.1M$1.6M$1.5M$2.2M$910.8K$4.3M$4.6M$5.8M$18.5M$22.1M$24.2M$29.2M$32.5M$33.6M$19.4M$21.9M$21.1M$21.0M$22.4M$18.0M
Accounts Payable And Accrued Liabilities Current$4.9M$4.5M$3.8M$2.7M$2.3M$1.3M$836.6K$1.7M$2.4M$1.9M$1.6M$2.1M$3.0M$1.8M$1.4M$2.0M$2.4M$2.5M$3.3M$2.3M$2.2M$1.5M
Cash And Cash Equivalents At Carrying Value$890.6K$17.5K$221.5K$224.6K$247.0K$390.1K$2.8M$1.6M$4.3M$11.2M$13.6M$15.6M$1.7M$2.8M$1.3M$740.9K$2.2M$3.1M$550.5K$127.8K
Repayments Of Notes Payable$17.3K$179.0K$1.8M$256.8K$27.1K$20.6K
Liabilities$2.2M$3.2M$5.0M$4.8M$7.0M$8.0M$9.2M$9.6M$10.2M$10.8M$12.9M$13.9M$13.8M$13.3M$13.1M$10.9M
Other Assets Current$66.2K$94.7K$1.0M$248.6K$197.0K$373.8K$528.8K$480.3K$958.8K$977.1K$514.8K$452.7K$337.0K$572.6K$332.0K$377.2K$401.0K
Property Plant And Equipment Net$800.3K$852.5K$904.7K$956.9K$1.0M$276.5K$565.8K$683.5K$1.8M$2.1M$2.3M$1.8M$1.9M$1.8M$1.9M$3.3M$3.5M$4.0M$3.6M$3.2M
Long Term Notes Payable$29.2K$35.1K$43.1K$53.0K$62.9K$72.6K$87.4K$121.8K$151.2K$87.4K$104.7K$2.7M$1.2M$320.4K$2.2M$2.0M$276.9K
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect-$473.3K-$204.0K-$373.1K-$2.8M$13.0M$908.3K$2.9M
Notes Payable Current$3.8M$1.9M$531.5K$1.5M$1.0M$14.9K$39.4K$44.3K$51.7K$58.9K$78.6K$92.8K$1.1M$1.9M$92.8K$254.5K$1.8M$4.5M$4.1M$1.4M$1.3M$3.0M
Accounts Receivable Net Current$28.0K$41.7K$15.8K$736.3K$678.6K$1.1M$2.9M$3.2M$3.1M$1.7M$1.2M$1.3M$1.8M$1.4M$1.5M$1.4M$777.7K$1.1M$665.1K
Repayments Of Debt And Capital Lease Obligations$1.7K$4.9K$4.7K$4.5K$4.3K$4.1K
Deposit Liability Current$125.2K$186.1K$205.4K$241.7K$552.0K$506.5K$332.5K$549.8K$413.2K$413.9K$373.7K$351.1K$292.5K$813.3K$1.3M$939.8K
Gain Loss On Disposition Of Assets1-$1.4M-$34.8K-$47.4K-$56.3K$49.00-$4.0K-$39.0K-$21.2K
Gain Loss On Disposition Of Assets-$2.3M-$301.9K$148.00-$3.8M-$34.8K-$47.4K
Intangible Assets Net Excluding Goodwill$869.0K$901.9K$1.2M$1.4M$5.4M$5.6M$6.5M$6.7M$6.8M$6.8M$7.1M$7.1M$7.4M$7.6M$4.1M
Other Assets$3.4M$5.3M$10.3M$14.6M$15.2M$13.8M$14.4M$13.5M$13.7M$13.7M$14.0M$14.8M$14.8M$10.6M
Liability To Issue Common Stock Current$292.2K$292.2K$329.9K$197.9K$387.2K$303.9K$394.6K$334.6K$364.6K$310.6K$326.4K$501.8K$312.3K$312.3K
Operating Lease Right Of Use Asset$896.8K$1.7M$1.9M$3.6M$4.0M$4.3M$4.6M$4.9M$5.0M$4.0M$4.0M$3.6M$3.8M$4.3M$4.0M$4.0M
Operating Lease Liability Noncurrent$747.5K$1.0M$1.3M$2.7M$3.0M$3.3M$3.7M$3.9M$4.3M$3.5M$3.7M$3.5M$3.7M$3.8M$3.5M$3.3M
Operating Lease Liability Current$316.3K$947.7K$996.8K$1.4M$1.4M$1.5M$1.5M$1.5M$1.4M$1.2M$1.1M$981.0K$1.0M$1.0M$623.4K$724.6K
Minority Interest-$4.6M-$3.4M-$2.9M-$2.6M-$2.4M-$2.4M-$2.4M-$2.5M-$2.4M-$2.1M
Finance Lease Liability Current$14.4K$16.9K$19.2K$19.9K$19.7K$19.5K$19.3K$18.8K$18.6K$25.7K$18.0K$17.9K$17.7K
Finance Lease Liability Noncurrent$2.6K$5.1K$9.4K$14.4K$19.4K$24.4K$34.1K$38.9K$43.6K$53.0K$57.5K$62.1K

Cash Flow Statement

Annual (10-K / 20-F)

Metric \ Fiscal YearFY2024FY2023FY2022FY2021FY2020FY2019FY2018
Share-Based Compensation *$35.4K$83.0K$444.5K$570.5K$392.1K$392.2K$15.0K
Operating Cash Flow *-$3.2M-$2.8M-$10.3M-$7.6M-$6.0M-$4.1M-$1.8M
Net Cash Provided By Used In Financing Activities$3.8M$4.0M$4.2M$14.5M$8.8M$5.3M$3.5M
Increase Decrease In Accounts Receivable$28.0K-$1.4M$1.8M-$304.4K$234.5K$412.8K$170.2K
Increase Decrease In Accounts Payable And Accrued Liabilities$5.1M-$388.5K-$820.6K$281.4K-$1.3M$1.4M$1.2M
Net Cash Provided By Used In Investing Activities-$375.0K-$1.8M-$260.0K-$2.5M-$569.7K-$1.1M-$1.6M
Increase Decrease In Patient Deposits-$241.7K-$79.3K$25.8K$105.4K-$264.7K$323.5K
Increase Decrease In Security Deposits$205.4K$56.6K$36.4K$111.1K-$111.4K-$410.3K
Increase Decrease In Other Current Assets-$180.2K$158.8K-$162.9K$271.7K$70.0K
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition$40.1K$95.1K$153.9K$150.1K$79.1K
Payments To Acquire Property Plant And Equipment$331.4K$694.4K$126.0K$1.2M$1.6M
Proceeds From Issuance Of Common Stock$16.7K$4.5M$19.0M$5.2M$1.3M
Proceeds From Notes Payable$1.6M$5.4M$212.8K$4.0M
Proceeds From Sale Of Property Plant And Equipment$1.0M$71.4K$24.5K$147.1K

Quarterly (10-Q, single quarters)

Metric \ QuarterQ1 2025Q3 2024Q1 2024Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021Q3 2020Q2 2020Q1 2020Q3 2019Q2 2019Q1 2019Q3 2018Q2 2018Q1 2018
Share-Based Compensation *$85.9K$84.1K$80.6K$40.6K$188.5K$123.2K$110.6K$108.4K$121.9K$81.1K$113.0K$171.6K$3.7K$3.7K$3.8K$3.7K
Operating Cash Flow *-$1.0M-$202.3K-$1.4M-$2.6M-$1.7M-$1.2M-$894.1K-$576.5K
Net Cash Provided By Used In Financing Activities$560.0K-$1.7K-$5.5K-$35.1K$15.4M$2.3M$3.8M$2.3M
Increase Decrease In Accounts Receivable-$28.0K-$45.5K-$184.6K$515.7K$332.5K$142.0K$361.5K$503.00
Increase Decrease In Accounts Payable And Accrued Liabilities$1.1M$176.4K$234.1K$499.8K$367.6K$408.2K$361.4K$136.7K
Net Cash Provided By Used In Investing Activities$1.1M-$216.1K-$683.1K-$207.2K-$42.4K-$1.3M
Increase Decrease In Patient Deposits-$36.3K$11.6K$118.8K$102.8K$485.4K-$22.2K
Increase Decrease In Security Deposits$53.7K$5.2K-$3.0K-$51.8K-$3.3K
Increase Decrease In Other Current Assets-$170.4K-$67.3K$167.2K-$64.1K$230.8K$118.4K
Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition$3.6K$27.7K$31.4K$31.1K$32.6K$39.1K$39.5K$39.1K$40.4K$37.6K$38.4K
Payments To Acquire Property Plant And Equipment$218.1K$65.8K$7.2K$42.4K$1.2M
Proceeds From Issuance Of Common Stock$100.0K$16.7K$148.6K$1.9M$17.2M$1.4M
Proceeds From Notes Payable$460.0K$1.2M$100.0K$2.3M
Proceeds From Sale Of Property Plant And Equipment$2.1K$1.3K

Per-Share & Share Counts

Annual (10-K / 20-F)

Metric \ Fiscal YearFY2024FY2023FY2022FY2021FY2020FY2019FY2018
Diluted EPS *-$5.76-$8.47-$19.43-$0.47-$0.50-$0.84-$0.47
Common Stock Shares Authorized120.0M2.0M60.0M30.0M30.0M30.0M
Common Stock Par Or Stated Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00
Common Stock Shares Issued1.1M1.1M26.9M12.8M8.9M4.5M
Preferred Stock Shares Authorized5.0M5.0M5.0M5.0M5.0M5.0M
Preferred Stock Par Or Stated Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00
Common Stock Shares Outstanding1.1M1.1M26.2M12.7M8.9M4.5M
Weighted Average Number Of Shares Outstanding Basic1.6M1.1M942.5K22.6M
Earnings Per Share Basic$-5.76$-8.47$-19.43$-0.47
Weighted Average Number Of Diluted Shares Outstanding1.6M1.1M942.5K

Quarterly (10-Q, single quarters)

Metric \ QuarterQ3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021Q3 2020Q2 2020Q1 2020Q3 2019Q2 2019Q1 2019Q3 2018Q2 2018Q1 2018
Diluted EPS *-$1.15-$0.89-$1.08-$1.76-$1.72$0.35-$2.63-$1.28-$3.36-$6.93-$0.07-$0.11-$0.10-$0.17-$0.12-$0.19-$0.22-$0.19-$0.23-$0.27-$0.22-$0.16-$0.09
Common Stock Shares Authorized120.0M120.0M120.0M120.0M60.0M60.0M60.0M2.0M60.0M60.0M60.0M30.0M30.0M30.0M30.0M30.0M30.0M30.0M30.0M30.0M30.0M
Common Stock Par Or Stated Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Common Stock Shares Issued3.8M3.8M3.8M2.0M2.0M1.5M1.1M1.1M33.3M33.0M32.8M27.5M27.0M26.0M26.0M24.7M11.8M11.8M10.0M8.5M8.3M7.3M
Preferred Stock Shares Authorized5.0M5.0M5.0M5.0M5.0M5.0M5.0M5.0M5.0M5.0M5.0M5.0M5.0M5.0M5.0M5.0M5.0M5.0M5.0M5.0M5.0M5.0M
Preferred Stock Par Or Stated Value Per Share$0.00$0.00$0.00$0.00$0.00$0.00$0.00$1,000.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Common Stock Shares Outstanding3.8M3.8M3.8M2.0M2.0M1.5M1.1M1.1M33.3M33.0M32.5M27.3M26.4M25.3M25.3M24.0M11.8M11.8M10.0M8.5M8.3M7.3M
Weighted Average Number Of Shares Outstanding Basic3.8M3.8M3.1M1.9M1.2M1.1M1.1M1.1M1.1M914.2K26.8M26.4M25.3M25.1M13.4M
Earnings Per Share Basic$-1.15$-0.89$-1.08$-1.76$-1.72$0.35$-2.63$-1.28$-3.36$-6.93$-0.07$-0.12$-0.07$-0.10$-0.17
Weighted Average Number Of Diluted Shares Outstanding3.8M3.8M3.1M1.9M1.2M1.1M1.1M1.1M1.1M914.2K26.8M

Other Metrics

Annual (10-K / 20-F)

Metric \ Fiscal YearFY2024FY2023FY2022FY2021FY2020FY2019FY2018
Salaries And Wages$1.3M$4.1M$13.3M$10.5M$10.5M$4.7M
Marketing And Advertising Expense$7.7K$74.0K$1.3M$933.3K$1.2M$859.2K
Patient Expenses$1.5M$1.6M$1.6M$2.5M$933.9K
Depreciation And Amortization$126.1K$654.8K$1.6M$1.7M$1.6M$651.1K
Additional Paid In Capital$55.2M$51.2M$46.1M$25.5M$20.1M$1.2M
Stock Issued During Period Value New Issues$4.5M$16.7K$4.9M$20.5M$5.3M$3.5M
Interest Paid Net$130.0K$14.2K$239.0K$63.2K$97.1K$153.8K
Investment Income Interest$3.5K$27.2K$9.8K$2.9K
Security Deposit$2.7K$357.1K$388.4K$499.5K$438.2K
Interest Income Other$2.9K$6.1K$7.8K$7.5K

Quarterly (10-Q, single quarters)

Metric \ QuarterQ3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022Q1 2022Q3 2021Q2 2021Q1 2021Q3 2020Q2 2020Q1 2020Q3 2019Q2 2019Q1 2019Q3 2018Q2 2018Q1 2018
Salaries And Wages$150.2K$912.2K$1.3M$637.8K$3.4M$3.9M$3.9M$3.4M$3.0M$2.8M$2.6M$2.3M$2.9M$2.9M$2.6M$2.1M$1.7M$588.5K$446.8K
Marketing And Advertising Expense$8.7K$36.8K$7.7K$244.6K$242.6K$370.5K$294.0K$315.5K$265.5K$234.7K$174.4K$241.8K$317.8K$349.3K$347.0K$291.7K$85.3K$93.2K
Patient Expenses$145.9K$175.7K$266.2K$279.8K$397.2K$460.5K$361.1K$340.0K$341.4K$428.6K$405.4K$379.8K$950.5K$927.8K$436.1K$339.9K$48.6K$37.1K
Depreciation And Amortization$77.2K$119.8K$47.2K$481.5K$438.6K$446.8K$450.6K$441.8K$422.2K$430.1K$453.7K$450.5K$422.4K$397.0K$285.6K$424.3K$89.2K$31.3K
Additional Paid In Capital$59.4M$59.5M$59.6M$59.3M$55.1M$55.4M$55.1M$51.3M$51.2M$51.2M$51.1M$47.3M$46.3M$44.8M$44.8M$42.7M$24.1M$24.1M$21.5M$18.9M$18.7M$14.3M
Stock Issued During Period Value New Issues$100.0K$47.4K$16.7K$3.8M$935.7K$148.6K$2.0M$17.2M$2.6M$1.4M$150.8K$3.5M
Interest Paid Net$40.6K$2.5K$4.6K$63.4K$27.4K$30.7K$23.6K
Investment Income Interest$39.00$185.00$1.5K$791.00$204.00$27.0K$1.00$2.00$2.8K$1.3K$1.8K
Security Deposit$150.5K$215.1K$246.7K$301.7K$351.8K$351.8K$357.1K$400.8K$391.5K$413.4K$451.3K$551.3K$498.1K$508.9K$441.5K
Interest Income Other$1.8K$6.0K$39.00$120.00$5.00$2.1K$2.1K$3.3K

Most recent annual filing with the SEC: April 15, 2025

Data sourced from SEC EDGAR public filings as of August 5, 2026.